Brain stimulation for better mobility in vision loss
Part of Brain & nervous system, Eyes & vision, Genetic & congenital clinical trials.
This study tests whether a safe, noninvasive brain stimulation technique (called tDCS) can help people with vision loss from retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma move around more easily and safely. Participants will do walking and orientation tasks while receiving the stimulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vision loss from retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma that narrows your side vision.
- Your vision (with glasses or contacts) is at least 20/40 in your better eye, but your side vision is limited to no more than 50 degrees in each eye.
- You are 18 or older and able to understand and follow instructions.
- You do not have dementia, cognitive impairment, or balance issues from another condition.
- You do not have epilepsy, a pacemaker, metal in your head, a brain tumor, or take certain psychiatric medications.
- You are not pregnant or trying to get pregnant, and you are willing to use your own white cane if you have one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a gentle electrical current applied to the scalp can improve vision in people with glaucoma. It uses a type of non-invasive brain stimulation called rtACS, which may help damaged optic nerves work better.
This trial tests whether combining a short vision learning program with non-invasive electrical stimulation to the brain can improve vision in people with open-angle or normal-tension glaucoma. It may help by training the visual system while stimulating brain pathways to support vision.
This study tests a non-invasive brain stimulation treatment to see if it can improve peripheral (side) vision in people with open-angle or normal-tension glaucoma. It targets people whose central vision is still relatively preserved but whose side vision has a measurable “gap” on vision testing.
This trial tests whether gentle electrical stimulation can help improve vision in people with moderate vision loss from glaucoma. It might offer a new way to strengthen remaining vision.
This trial studies whether electrical stimulation can help improve vision in people with glaucoma-related optic nerve damage. You may qualify if your visual field test shows moderate to severe loss and your eye pressure is stable.
This study focuses on adults with macular degeneration and aims to improve how well you can use your remaining vision. It uses learning and brain stimulation, so it may help you notice and use your vision more effectively.
Hear when a new Vision Loss Partial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.